参考文献/References:
[1] Chen WQ,Zhang SW,Zou XN,et al.Cancer incidence and mortality in China,2006[J].Chinese Journal of Cancer Research,2011,23(1):39.
[2] 〖JP2〗Halsted CP,Benson JR,Jatoi I.A historical account of breast cancer surgery:beware of local recurrence but be not radical.[J].Future Oncology,2014,10(9):16491657.〖JP〗
[3] Montalvo DN,Nicolas Gonzalez M,María T Montalvo V,et al.Patterns of recurrence and survival in breast cancer[J].Oncology Reports,2008,20(3):531535.
[4] Roth BJ,Krilov L,Adams S,et al.Clinical cancer advances 2012:annual report on progress against cancer from the american society of clinical oncology[J].J Clin Oncol,2013,31(1):131161.
[5] 〖JP2〗Desantis C,Ma J,Bryan L,et al.Breast cancer statistics,2013[J].Ca A Cancer Journal for Clinicians,2014,64(1):5262.〖JP〗
[6] 陈建萍,赵淑华,卓灏柘,等.中医防治乳腺癌复发与转移的策略与方法[J].环球中医药,2011,4(2):125128.
[7] 任黎萍,张晓清.归脾汤和龟鹿二仙汤加减治疗乳腺癌化疗后骨髓抑制50例[J].陕西中医,2009,30(7):2829.
[8] 李茂林,孙显峰.益气升白汤治疗乳腺癌化疗后白细胞减少症109例[J].陕西中医,2010,31(2):56.
[9] 余 静.沈力主任医师对肿瘤放化疗不良反应的中医辨证施治[J].浙江中医药大学学报,2005,29(5):3738.
[10] 余文亚,沈 力.益气养阴解毒汤辅助放化疗治疗鼻咽癌临床观察[J].新中医,2016,48(12):142144.
[11] 湛 丽,谢丰培,傅明杰.乳腺癌组织发生的同源性与形态分化的多向性[J].临床与实验病理学杂志,2004,20(1):9193.
[12] 陈 丽,叶丽红.乳腺癌手术前后的病证分型[J].长春中医药大学学报,2008,24(3):276277.
[13] 〖JP3〗富 琦,王 皓,韩 冬,等.乳腺癌术后患者化疗前后中医证候变化的临床研究[J].北京中医药,2012,31(1):46.〖JP〗
[14] 吴雪雪,杨 毅,时光喜.姜兆俊从肾虚论治乳腺增生病经验[J].实用中医药杂志,2013,29(12):1056.
[15] 王登正,刘佩珍,张洪亮,等.论肿瘤治疗的“屡攻屡补,以平为期”原则[J].新疆中医药,2008,26(5):7475.
相似文献/References:
[1]陈 楠,王光辉△,贺 赛,等.养正合剂改善乳腺癌术后化疗者不适及对患者细胞因子、红细胞免疫的影响[J].陕西中医,2019,(10):1357.
CHEN Nan,WANG Guanghui,HE Sai,et al.Yangzheng mixture improves the discomfort of postoperative chemotherapy in patients with breast cancer and its immunity to cytokines and red blood cells[J].,2019,(1):1357.
[2]张贺,姜大庆.鸦胆子素D对乳腺癌MDAMB231细胞增殖与凋亡及细胞周期的影响*[J].陕西中医,2019,(11):1495.
ZHANG He,JIANG Daqing..Effects of Bruceine D on proliferation,apoptosis and cell cycle of breast cancer MDAMB231 cells[J].,2019,(1):1495.
[3]张栓宝,张燕平△,严宁娟.康莱特注射液对乳腺癌新辅助化疗患者免疫功能、血管内皮生长因子及生活质量的影响[J].陕西中医,2019,(11):1566.
ZHANG Shuanbao,ZHANG Yanping,YAN Ningjuan..Effect of Kanglaite injection on immune function,VEGF and quality of life in patients with breast cancer receiving neoadjuvant chemotherapy[J].,2019,(1):1566.
[4]刘歆春,李锁南,黄飞燕.乳岩汤联合西药治疗乳腺癌疗效及对患者免疫功能的影响[J].陕西中医,2021,(9):1201.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.012]
[5]冯秀梅,马 兰,罗玉群,等.益气活血方对乳腺癌MCF-7细胞系增殖侵袭能力及miR-100表达水平影响的研究[J].陕西中医,2021,(11):1527.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.007]
FENG Xiumei,MA Lan,LUO Yuqun,et al.Yiqi Huoxue recipe to inhibit breast cancer cell proliferation and invasion and increase the expression of miR-100[J].,2021,(1):1527.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.007]
[6]陈 军,孙 嫘,惠建荣,等.艾灸对三阴性乳腺癌移植瘤小鼠生存期的影响及机制研究[J].陕西中医,2022,(7):819.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.001]
CHEN Jun,SUN Lei,HUI Jianrong,et al.Effect and mechanism of moxibustion on survival of triple negative breast cancer transplanted tumor mice[J].,2022,(1):819.[doi:DOI:10.3969/j.issn.1000-7369.2022.07.001]
[7]陈明明,郭 旭,熊乙霓,等.培元固本法治疗乳腺癌化疗后骨髓抑制临床研究[J].陕西中医,2022,(8):1049.[doi:DOI:10.3969/j.issn.1000-7369.2022.08.014]
[8]蔡丽珍,白瑞娜,张 路,等.基于“痰夹瘀血”理论探讨乳腺癌相关淋巴水肿因机治疗[J].陕西中医,2023,(10):1420.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.019]
CAI Lizhen,BAI Ruina,ZHANG Lu,et al.Based on the theory of “phlegm blended with blood stasis”,to explore the mechanism and treatment of breast cancer related lymphedema[J].,2023,(1):1420.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.019]
[9]宋铁兵,李康乐,马 强,等.土贝母皂苷甲对乳腺癌细胞MCF-7凋亡的影响[J].陕西中医,2023,(11):1514.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.004]
SONG Tiebing,LI Kangle,MA Qiang,et al.Effect of Tubeimoside I on apoptosis of breast cancer cell MCF-7[J].,2023,(1):1514.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.004]
[10]高 宏,周立江,邢向荣,等.柴胡龙骨牡蛎汤加减治疗乳腺癌研究进展[J].陕西中医,2023,(11):1657.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.040]
GAO Hong,ZHOU Lijiang,XING Xiangrong,et al.Research progress of Chaihu Longgu Muli decoction in treatment of breast cancer[J].,2023,(1):1657.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.040]